Charles River (CRL) Extends Gene Therapy Offering With New Pact
https://www.zacks.com/stock/news/2241549/charles-river-crl-extends-gene-therapy-offering-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2241549
Mar 15, 2024 - Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
0
Labcorp (LH) Presents New Research on Precision Diagnostics
https://www.zacks.com/stock/news/2242254/labcorp-lh-presents-new-research-on-precision-diagnostics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242254
Mar 18, 2024 - Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
0
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
https://www.zacks.com/stock/news/2243024/inspira-technologies-iinn-strives-to-get-amar-nod-for-art100?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243024
Mar 19, 2024 - The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
0
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
https://www.zacks.com/stock/news/2242630/here-s-why-you-should-retain-tandem-diabetes-tndm-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242630
Mar 19, 2024 - Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
0
Here's Why Investors Should Retain Abbott (ABT) Stock Now
https://www.zacks.com/stock/news/2243034/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243034
Mar 19, 2024 - Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre.
0
Top Stock Reports for Disney, Morgan Stanley & Stryker
https://www.zacks.com/commentary/2244021/top-stock-reports-for-disney-morgan-stanley-stryker?cid=CS-ZC-FT-research_daily-2244021
Mar 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Morgan Stanley (MS) and Stryker Corporation (SYK).
0
Reasons to Add Stryker (SYK) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2244193/reasons-to-add-stryker-syk-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2244193
Mar 21, 2024 - Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
0
Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark
https://www.zacks.com/stock/news/2246922/abbott-s-abt-assert-iq-cardiac-monitor-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246922
Mar 27, 2024 - Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2247607/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247607
Mar 28, 2024 - Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
0
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
https://www.zacks.com/stock/news/2248657/labcorp-lh-to-boost-clinical-diagnostics-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2248657
Apr 01, 2024 - The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
0